Structural and (patho)physiological diversity of PAF. (Q40521616)

21 September 2017

1 reference

title

Structural and (patho)physiological diversity of PAF. (English)

1 reference

21 September 2017

R N Pinckard

1

1 reference

21 September 2017

D S Woodard

2

1 reference

21 September 2017

H J Showell

3

1 reference

21 September 2017

M J Conklyn

4

1 reference

21 September 2017

M J Novak

5

1 reference

21 September 2017

L M McManus

6

1 reference

21 September 2017

1 January 1994

1 reference

Clinical reviews in allergy

21 September 2017

1 reference

21 September 2017

12

1 reference

21 September 2017

4

1 reference

21 September 2017

329-359

1 reference

Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factor.

21 September 2017

1 reference

12 December 2020

Identification of sn-2-omega-hydroxycarboxylate-containing phospholipids in a lipid extract from bovine brain.

1 reference

12 December 2020

Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells

1 reference

12 December 2020

Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage

1 reference

12 December 2020

Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids

1 reference

12 December 2020

A comparative study of the effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet activating factor on histamine and leukotriene C4 release from human leukocytes.

1 reference

12 December 2020

Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen

1 reference

12 December 2020

Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family

1 reference

12 December 2020

Synthesis of 1-acyl-2-[3H]acetyl-SN-glycero-3-phosphocholine, a structural analog of platelet activating factor, by vascular endothelial cells

1 reference

12 December 2020

Binding of platelet activating factor to albumin

1 reference

12 December 2020

Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells

1 reference

12 December 2020

P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia

1 reference

12 December 2020

Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms

1 reference

12 December 2020

Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids

1 reference

12 December 2020

The metabolic effects of platelet-activating factor antagonism in endotoxemic man

1 reference

12 December 2020

Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell

1 reference

12 December 2020

Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes

1 reference

12 December 2020

Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells.

1 reference

12 December 2020

The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma

1 reference

12 December 2020

Synthesis of pentafluorobenzoic anhydride: a superior derivatizing agent for lipids

1 reference

12 December 2020

Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor

1 reference

12 December 2020

Perspectives in platelet-activating factor research

1 reference

12 December 2020

Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.

1 reference

12 December 2020

Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues.

1 reference

12 December 2020

Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings

1 reference

12 December 2020

Formation of platelet-activating factor-like phospholipids by Fe2+/ascorbate/EDTA-induced lipid peroxidation.

1 reference

12 December 2020

Juxtacrine intercellular signaling: another way to do it.

1 reference

12 December 2020

Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes

1 reference

12 December 2020

Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils.

1 reference

12 December 2020

Alkyl chain homologs of platelet-activating factor and their effects on the mammalian heart

1 reference

12 December 2020

Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis

1 reference

12 December 2020

PAF-acether and acetylhydrolase in stool of patients with Crohn's disease

1 reference

12 December 2020

Platelet-activating factor: a phospholipid autacoid with diverse actions.

1 reference

12 December 2020

Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung

1 reference

12 December 2020

Structure elucidation of platelet activating factor derived from human neutrophils

1 reference

12 December 2020

Acyl type platelet-activating factor in normal rat uterus determined by gas chromatography mass spectrometry

1 reference

12 December 2020

Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil

1 reference

12 December 2020

PAF. A review of its effects, antagonists and possible future clinical implications (Part II)

1 reference

12 December 2020

Platelet-activating factor: receptors and signal transduction

1 reference

12 December 2020

Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress

1 reference

12 December 2020

Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study.

1 reference

12 December 2020

Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)

1 reference

12 December 2020

Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain

1 reference

12 December 2020

Fast atom bombardment-mass spectrometric identification of molecular species of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes.

1 reference

12 December 2020

1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes

1 reference

12 December 2020

Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine

1 reference

12 December 2020

Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine

1 reference

12 December 2020

Human neutrophil platelet-activating factor: molecular heterogeneity in unstimulated and ionophore-stimulated cells

1 reference

12 December 2020

Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187

1 reference

12 December 2020

Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils

1 reference

12 December 2020

Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I)

1 reference

12 December 2020

The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction

1 reference

12 December 2020

Species-specific variations in the molecular heterogeneity of the platelet-activating factor

1 reference

12 December 2020

Release of newly synthesized platelet-activating factor (PAF) from human polymorphonuclear leukocytes under in vivo conditions. Contribution of PAF-releasing factor in serum

1 reference

12 December 2020

Comparative effects of cytochrome P-450 inhibitors on Ca2+ and Mn2+ entry induced by agonists or by emptying the Ca2+ stores of human neutrophils.

1 reference

12 December 2020

Quantitative analysis of platelet-activating factor in human plasma. Application to patients with liver cirrhosis and disseminated intravascular coagulation

1 reference

12 December 2020

Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy

1 reference

12 December 2020

High affinity receptor binding of platelet-activating factor in rat peritoneal polymorphonuclear leukocytes

1 reference

12 December 2020

Resistance and exchange microvessels are modulated by different PAF receptors

1 reference

12 December 2020

Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man

1 reference

12 December 2020

Inflammatory roles of P-selectin

1 reference

12 December 2020

Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells

1 reference

12 December 2020

The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion

1 reference

12 December 2020

Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs

1 reference

12 December 2020

PAF molecular heterogeneity: pathobiological implications.

1 reference

12 December 2020

Analysis of platelet-activating factor by GC-MS after direct derivatization with pentafluorobenzoyl chloride and heptafluorobutyric anhydride

1 reference

12 December 2020

Application of selected ion monitoring to determination of platelet-activating factor

1 reference

12 December 2020

Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine

1 reference

12 December 2020

Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man

1 reference

12 December 2020

Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects

1 reference

12 December 2020

The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog

1 reference

12 December 2020

Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects

1 reference

12 December 2020

Metabolism of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil

1 reference

12 December 2020

Differential actions of platelet-activating factor (PAF) receptor antagonists on the vasodilator and vasoconstrictor effects of PAF in the rat perfused heart

1 reference

12 December 2020

Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects

1 reference

12 December 2020

Binding and metabolism of platelet-activating factor by human neutrophils

1 reference

12 December 2020

Novel molecular analogues of phosphatidylcholines in a lipid extract from bovine brain: 1-long-chain acyl-2-short-chain acyl-sn-glycero-3-phosphocholines

1 reference

12 December 2020

Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group

1 reference

12 December 2020

Identifiers

1 reference